|
Evidence-Based Approaches to Smoking Cessation in Patients with Cancer |
0.50 |
06/16/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Evolution of Immunotherapy and Management of Complex Toxicities |
1.00 |
05/20/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Evolving Concepts in the Diagnosis and Staging of Multiple Myeloma |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
|
Genetics/Familial Risk Assessment for Breast Cancer: Controversies and Evolving Principles |
0.50 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
|
Immune Checkpoint Inhibitor Toxicities |
0.75 |
05/08/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Implementing Clinical Trials in the Community Setting |
0.50 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Improving Efficiency and the Patient Experience in the Ambulatory Setting |
1.00 |
06/05/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Interactive Online Case Studies: Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Disorders - Case 1 |
0.25 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
|
Interactive Online Case Studies: Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Disorders - Case 2 |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
|
Interactive Online Case Studies: Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Disorders - Case 3 |
0.25 |
11/17/2020 - 12:00am to 10/30/2021 - 12:00am |
|
Interactive Online Case Studies: Lymphoma - Case 1 |
0.25 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
|
Interactive Online Case Studies: Lymphoma - Case 2 |
0.25 |
11/25/2020 - 12:00am to 10/30/2021 - 12:00am |
|
Interactive Online Case Studies: Lymphoma - Case 3 |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
|
Interactive Online Case Studies: Plasma Cell Neoplasms - Case 1 |
0.25 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
|
Interactive Online Case Studies: Plasma Cell Neoplasms - Case 2 |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Facebook
Twitter
LinkedIn
Forward